RT Journal Article SR Electronic T1 PHARMACOLOGY OF RHODEXIN A JF Journal of Pharmacology and Experimental Therapeutics JO J Pharmacol Exp Ther FD American Society for Pharmacology and Experimental Therapeutics SP 365 OP 368 VO 146 IS 3 A1 Kenzo Kikuchi A1 K. K. Chen YR 1964 UL http://jpet.aspetjournals.org/content/146/3/365.abstract AB The cardiotonic action of rhodexin A, sarmentogenin rhamnoside, has been confirmed both qualitatively and quantitatively. The geometric mean dose in etherized cats is 0.1059 ± 0.0028 mg/kg. The degree of intestinal absorption is estimated by measuring the median emetic dose in groups of etherized cats following intrajejunal and intravenous injections because vomiting response precedes electrocardiographic changes. About 20% of rhodexin A and 75% Of digitoxin are absorbed from the jejunum. By direct perfusion of the sinus node of the dog's heart, the chronotropic effect of rhodexin A is found comparable to that of acetylstrophanthidin, but longer and more intense. DCI, procaine amide, visnadin, and α-methyl-β-hydroxy-β(2,5-diethoxyphenyl)-N-isopropyl-ethylamine are tested for their antiarrhythmic action against rhodexin A-induced ventricular tachycardia in cats. Visnadin is inactive, while the other three compounds are capable of restoring sinus rhythm in various doses. There is a suggestion that the last product is slightly more potent than the other two. The Williams & Wilkins Comapny